Dr. Autumn Frandsen, ND
Summary
This case describes a 71-year-old feminine presenting with acute-onset neuropsychiatric and systemic signs following relocation to a brand new workplace surroundings. Laboratory analysis revealed elevated complement part C4a and multi-class mycotoxin positivity, together with markedly elevated ochratoxin A. Extra findings demonstrated mold-specific immune reactivity with no full continual inflammatory response syndrome (CIRS) profile. Preliminary therapy with activated charcoal and phosphatidylcholine resulted in gentle enchancment and partial discount in inflammatory markers. Subsequent addition of oral immunotherapy and L-theanine led to additional enchancment in neuropsychiatric signs. Escalation of binding remedy with a bile acid sequestrant resulted in substantial restoration over two months. Persistent insomnia resolved following titration of intravenous glutathione. This case highlights the significance of differentiating mycotoxin sickness from CIRS and emphasizes the function of therapy sequencing in advanced environmental sickness.
Introduction
Mycotoxins are biologically energetic compounds able to disrupting mobile membranes, impairing mitochondrial operate, and altering immune signaling. Medical manifestations might contain a number of techniques, together with neurological, gastrointestinal, and musculoskeletal domains.
Environmental sickness exists alongside a spectrum. Whereas continual inflammatory response syndrome (CIRS) represents a well-described subset characterised by particular biomarker patterns and immune dysregulation, not all sufferers with mycotoxin publicity meet standards for CIRS. Differentiating between these entities might have necessary implications for therapy technique.
Case Presentation
A 71-year-old feminine with no prior psychiatric historical past introduced with sudden onset of:
- Extreme nervousness
- Insomnia
- Cognitive dysfunction
- Fatigue
- Extreme neck and shoulder ache
- Stomach ache
- New intolerance to beforehand well-tolerated meals
Signs started inside months of shifting into a brand new workplace constructing, suggesting a possible environmental set off.
Differential Analysis
Thought-about etiologies included:
- Major psychiatric dysfunction
- Neuroinflammatory or neurodegenerative illness
- Endocrine dysfunction
- Power an infection (Lyme illness, EBV)
- Power inflammatory response syndrome (CIRS)
- Environmental toxin publicity (together with mycotoxins)
The acute onset, lack of psychiatric historical past, and environmental correlation made a main psychiatric etiology much less possible.
Etiological Concerns
Mycotoxin publicity was suspected based mostly on environmental timing and symptom sample. Mycotoxins comparable to ochratoxin, gliotoxin, and trichothecenes are identified to:
- Disrupt lipid membranes
- Induce oxidative stress
- Alter immune signaling
- Have an effect on central nervous system operate
On this case, each toxin burden and immune sensitization appeared to contribute to illness expression.
Diagnostic Evaluation
Inflammatory and Regulatory Markers
- C4a: 5600 (elevated)
- TGF-β1: 7210 (markedly elevated)
- MMP-9: regular
- VEGF: regular
- MSH: regular
- ADH/osmolality: regular
Mycotoxin Testing
- Elevated ochratoxin A
- Elevated gliotoxin
- Presence of aflatoxins, trichothecenes, zearalenone
- Lyme illness: destructive
- Epstein Barr Virus: destructive
Medical Interpretation
Findings indicated:
- Important toxin burden
- Partial inflammatory activation
The absence of widespread biomarker abnormalities prompt a non-CIRS mycotoxin sickness with immune involvement.
CIRS vs Mycotoxin Sickness
CIRS:
- Broad biomarker dysregulation
- Persistent innate immune activation
Non-CIRS Mycotoxin Sickness:
- Selective biomarker abnormalities
- Might embody immune sensitization with out full systemic dysregulation
This affected person’s profile aligned with the latter.
Therapeutic Intervention
Preliminary Intervention: Binding and Membrane Help
- Activated charcoal 500 mg twice day by day
- Phosphatidylcholine 300–600 mg day by day
Medical Response:
- Gentle enchancment in nervousness
- Gentle cognitive enchancment
Observe-Up Laboratory Evaluation
After preliminary remedy:
- C4a decreased from 5600 → 3500
- TGF-β1 decreased from 7210 → 6500
These findings indicated partial discount in inflammatory signaling, regardless of persistent signs.
At the moment, mould IgE and IgG testing have been carried out to attempt to verify whether or not the persistent signs have been exacerbated by constant publicity, confirming important immune sensitization.
Mildew Immune Reactivity
IgE:
- Cladosporium herbarum: 2.4
- Penicillium chrysogen: 4.1
- Remaining panel: destructive
IgG:
Broad elevation throughout a number of molds (together with Cladosporium, Aspergillus, Setomelanomma, Curvularia)
- Medical Interpretation of Findings Indicated: Robust mold-specific immune sensitization
Intermediate Intervention: Immune Modulation and Neuroregulation
- Oral immunotherapy (1 → 5 drops over 5 weeks)
- L-theanine 200 mg 3 times day by day
Medical Response:
- Substantial discount in nervousness
- Improved cognitive readability
- Improved emotional stability
Escalation of Binding Remedy
- Cholestyramine launched
Medical Response (2 months):
- Decision of fatigue
- Decision of ache
- Improved GI signs
- Diminished meals intolerance
Last Intervention: Glutathione
- IV glutathione titrated from 1000 mg → 3000 mg over 6 weeks
Medical Response:
Consequence
- Neuropsychiatric signs resolved
- Systemic signs improved
- Sleep normalized
Dialogue
Goal enchancment might precede symptom decision
Early reductions in C4a and TGF-β1 counsel physiologic enchancment earlier than full scientific restoration.
Immune sensitization can maintain signs
Persistent immune reactivity possible contributed to ongoing neuropsychiatric signs.
Neuroimmune dysregulation is central
Disrupted immune–nervous system communication possible performed a key function.
Remedy sequencing is crucial
Enchancment adopted staged development:
- Binding + membrane assist
- Immune modulation + neuroregulation
- Enhanced binding
- Antioxidant assist
Glutathione as a late-stage intervention
Efficient for residual signs as soon as upstream processes have been addressed.
Conclusion
This case demonstrates that mycotoxin-associated sickness might current with no full CIRS biomarker profile and should require a staged therapeutic method. Early enhancements in inflammatory markers might not correspond to full symptom decision when immune dysregulation persists. Addressing toxin burden, immune sensitization, and neuroregulation in sequence might optimize scientific outcomes.
Autumn Frandsen, ND is a licensed naturopathic doctor specializing in environmental medication, advanced continual sickness, and toxin-mediated illness. She practices with the Nationwide Affiliation of Environmental Medication (NAEM), the place she focuses on circumstances comparable to mycotoxin sickness, continual inflammatory response syndromes, neuroimmune dysregulation, and environmentally acquired sensitivities.
Dr. Frandsen’s scientific method integrates purposeful laboratory evaluation, toxin-binding methods, immune modulation, mitochondrial assist, and individualized detoxing protocols. She has explicit experience in differentiating overlapping environmental and inflammatory circumstances and making use of structured, sequential therapy methods to optimize affected person outcomes.
She is dedicated to evidence-informed, systems-based care and to advancing clinician schooling within the recognition and therapy of environmentally pushed sickness, with an emphasis on restoring physiologic resilience and long-term well being.
References:
- Bennett JW, Klich M. Mycotoxins. Clin Microbiol Rev. 2003;16(3):497-516.
doi:10.1128/CMR.16.3.497-516.2003 - Pestka JJ. Deoxynivalenol: mechanisms of motion, human publicity, and toxicological relevance. Arch Toxicol. 2010;84(9):663-679.
doi:10.1007/s00204-010-0579-8 - Peraica M, Radic B, Lucic A, Pavlovic M. Poisonous results of mycotoxins in people. Bull World Well being Organ. 1999;77(9):754-766.
doi:10.1590/S0042-96861999000900007 (archival DOI reference) - Hope J. A evaluation of the mechanism of damage and therapy approaches for sickness ensuing from publicity to water-damaged buildings, mould, and mycotoxins. Sci World J. 2013;2013:767482.
doi:10.1155/2013/767482 - Shoemaker RC, Home DE. A time-series examine of sick constructing syndrome: continual inflammatory response syndrome. Neurotoxicol Teratol. 2006;28(5):573-588.
doi:10.1016/j.ntt.2006.05.003 - Islam Z, Amuzie CJ, Harkema JR, Pestka JJ. Neuroimmune and proinflammatory gene expression in mice uncovered to trichothecene mycotoxins. Toxicol Sci. 2006;92(2):645-655.
doi:10.1093/toxsci/kfj212 - Ratnaseelan AM, Tsilioni I, Theoharides TC. Results of mycotoxins on neuropsychiatric signs and immune processes. Clin Ther. 2018;40(6):903-917.
doi:10.1016/j.clinthera.2018.05.007 - Theoharides TC, et al. Mast cells and irritation in environmental sickness. J Neuroinflammation. 2012;9:168.
doi:10.1186/1742-2094-9-168 - Reddy RV, et al. Ochratoxin A induces oxidative stress and mitochondrial dysfunction. Toxicology. 2010;271(1-2):1-8.
doi:10.1016/j.tox.2010.02.006 - Marin S, Ramos AJ, Cano-Sancho G, Sanchis V. Mycotoxins: incidence, toxicology, and publicity evaluation. Meals Chem Toxicol. 2013;60:218-237.
doi:10.1016/j.fct.2013.07.047 - Phillips TD, Afriyie-Gyawu E, Williams J, et al. Lowering human publicity to aflatoxins via enterosorption. Toxicol Sci. 2008;101(2):270-279.
doi:10.1093/toxsci/kfm268 - Hofmann AF. Bile acid sequestrants and ldl cholesterol metabolism. Gastroenterology. 1998;114(3):525-536.
doi:10.1016/S0016-5085(98)70538-3 - Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA. N-acetylcysteine—a secure antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol. 2007;7(4):355-359.
doi:10.1016/j.coph.2007.04.005 - Townsend DM, Tew KD, Tapiero H. The significance of glutathione in human illness. Biomed Pharmacother. 2003;57(3-4):145-155.
doi:10.1016/S0753-3322(03)00043-X - Nicolson GL. Lipid substitute remedy: a purposeful method to mitochondrial dysfunction. J Am Nutr Assoc. 2014;17(3):30-38.
doi:10.1080/07315724.2014.10719372 - Sezgin E, Levental I, Mayor S, Eggeling C. The thriller of membrane group: lipid rafts. Nat Rev Mol Cell Biol. 2017;18(6):361-374.
doi:10.1038/nrm.2017.16